Standard

Candidate SNP markers of familial and sporadic Alzheimer's diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters. / Ponomarenko, Petr; Chadaeva, Irina; Rasskazov, Dmitry A. et al.

In: Frontiers in Aging Neuroscience, Vol. 9, No. JUL, 231, 20.07.2017, p. 231.

Research output: Contribution to journalArticlepeer-review

Harvard

Ponomarenko, P, Chadaeva, I, Rasskazov, DA, Sharypova, E, Kashina, EV, Drachkova, I, Zhechev, D, Ponomarenko, MP, Savinkova, LK & Kolchanov, N 2017, 'Candidate SNP markers of familial and sporadic Alzheimer's diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters', Frontiers in Aging Neuroscience, vol. 9, no. JUL, 231, pp. 231. https://doi.org/10.3389/fnagi.2017.00231

APA

Ponomarenko, P., Chadaeva, I., Rasskazov, D. A., Sharypova, E., Kashina, E. V., Drachkova, I., Zhechev, D., Ponomarenko, M. P., Savinkova, L. K., & Kolchanov, N. (2017). Candidate SNP markers of familial and sporadic Alzheimer's diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters. Frontiers in Aging Neuroscience, 9(JUL), 231. [231]. https://doi.org/10.3389/fnagi.2017.00231

Vancouver

Ponomarenko P, Chadaeva I, Rasskazov DA, Sharypova E, Kashina EV, Drachkova I et al. Candidate SNP markers of familial and sporadic Alzheimer's diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters. Frontiers in Aging Neuroscience. 2017 Jul 20;9(JUL):231. 231. doi: 10.3389/fnagi.2017.00231

Author

Ponomarenko, Petr ; Chadaeva, Irina ; Rasskazov, Dmitry A. et al. / Candidate SNP markers of familial and sporadic Alzheimer's diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters. In: Frontiers in Aging Neuroscience. 2017 ; Vol. 9, No. JUL. pp. 231.

BibTeX

@article{5c8a83a1e0a24c5581f996de48f6fef8,
title = "Candidate SNP markers of familial and sporadic Alzheimer's diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters",
abstract = "While year after year, conditions, quality, and duration of human lives have been improving due to the progress in science, technology, education, and medicine, only eight diseases have been increasing in prevalence and shortening human lives because of premature deaths according to the retrospective official review on the state of US health, 1990-2010. These diseases are kidney cancer, chronic kidney diseases, liver cancer, diabetes, drug addiction, poisoning cases, consequences of falls, and Alzheimer's disease (AD) as one of the leading pathologies. There are familial AD of hereditary nature (~4% of cases) and sporadic AD of unclear etiology (remaining ~96% of cases; i.e., non-familial AD). Therefore, sporadic AD is no longer a purely medical problem, but rather a social challenge when someone asks oneself: {"}What can I do in my own adulthood to reduce the risk of sporadic AD at my old age to save the years of my lifespan from the destruction caused by it?{"} Here, we combine two computational approaches for regulatory SNPs: Web service SNP_TATA_Comparator for sequence analysis and a PubMed-based keyword search for articles on the biochemical markers of diseases. Our purpose was to try to find answers to the question: {"}What can be done in adulthood to reduce the risk of sporadic AD in old age to prevent the lifespan reduction caused by it?{"} As a result, we found 89 candidate SNP markers of familial and sporadic AD (e.g., rs562962093 is associated with sporadic AD in the elderly as a complication of stroke in adulthood, where natural marine diets can reduce risks of both diseases in case of the minor allele of this SNP). In addition, rs768454929, and rs761695685 correlate with sporadic AD as a comorbidity of short stature, where maximizing stature in childhood and adolescence as an integral indicator of health can minimize (or even eliminate) the risk of sporadic AD in the elderly. After validation by clinical protocols, these candidate SNP markers may become interesting to the general population [may help to choose a lifestyle (in childhood, adolescence, and adulthood) that can reduce the risks of sporadic AD, its comorbidities, and complications in the elderly].",
keywords = "Alzheimer's disease, Expression change, Gene, Promoter, Single nucleotide polymorphism, SNP marker, TATA-binding protein, TBP-binding site, TRANSCRIPTION FACTOR-BINDING, MYOCARDIAL-INFARCTION, gene, single nucleotide polymorphism, AMYOTROPHIC-LATERAL-SCLEROSIS, POLYMERASE-II TRANSCRIPTION, SENILE PLAQUES, DIABETES-MELLITUS, HUMAN HEREDITARY-DISEASES, expression change, AMYLOID-BETA, MOUSE MODEL, promoter, PARKINSONS-DISEASE",
author = "Petr Ponomarenko and Irina Chadaeva and Rasskazov, {Dmitry A.} and Ekaterina Sharypova and Kashina, {Elena V.} and Irina Drachkova and Dmitry Zhechev and Ponomarenko, {Mikhail P.} and Savinkova, {Ludmila K.} and Nikolay Kolchanov",
year = "2017",
month = jul,
day = "20",
doi = "10.3389/fnagi.2017.00231",
language = "English",
volume = "9",
pages = "231",
journal = "Frontiers in Aging Neuroscience",
issn = "1663-4365",
publisher = "Frontiers Media S.A.",
number = "JUL",

}

RIS

TY - JOUR

T1 - Candidate SNP markers of familial and sporadic Alzheimer's diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters

AU - Ponomarenko, Petr

AU - Chadaeva, Irina

AU - Rasskazov, Dmitry A.

AU - Sharypova, Ekaterina

AU - Kashina, Elena V.

AU - Drachkova, Irina

AU - Zhechev, Dmitry

AU - Ponomarenko, Mikhail P.

AU - Savinkova, Ludmila K.

AU - Kolchanov, Nikolay

PY - 2017/7/20

Y1 - 2017/7/20

N2 - While year after year, conditions, quality, and duration of human lives have been improving due to the progress in science, technology, education, and medicine, only eight diseases have been increasing in prevalence and shortening human lives because of premature deaths according to the retrospective official review on the state of US health, 1990-2010. These diseases are kidney cancer, chronic kidney diseases, liver cancer, diabetes, drug addiction, poisoning cases, consequences of falls, and Alzheimer's disease (AD) as one of the leading pathologies. There are familial AD of hereditary nature (~4% of cases) and sporadic AD of unclear etiology (remaining ~96% of cases; i.e., non-familial AD). Therefore, sporadic AD is no longer a purely medical problem, but rather a social challenge when someone asks oneself: "What can I do in my own adulthood to reduce the risk of sporadic AD at my old age to save the years of my lifespan from the destruction caused by it?" Here, we combine two computational approaches for regulatory SNPs: Web service SNP_TATA_Comparator for sequence analysis and a PubMed-based keyword search for articles on the biochemical markers of diseases. Our purpose was to try to find answers to the question: "What can be done in adulthood to reduce the risk of sporadic AD in old age to prevent the lifespan reduction caused by it?" As a result, we found 89 candidate SNP markers of familial and sporadic AD (e.g., rs562962093 is associated with sporadic AD in the elderly as a complication of stroke in adulthood, where natural marine diets can reduce risks of both diseases in case of the minor allele of this SNP). In addition, rs768454929, and rs761695685 correlate with sporadic AD as a comorbidity of short stature, where maximizing stature in childhood and adolescence as an integral indicator of health can minimize (or even eliminate) the risk of sporadic AD in the elderly. After validation by clinical protocols, these candidate SNP markers may become interesting to the general population [may help to choose a lifestyle (in childhood, adolescence, and adulthood) that can reduce the risks of sporadic AD, its comorbidities, and complications in the elderly].

AB - While year after year, conditions, quality, and duration of human lives have been improving due to the progress in science, technology, education, and medicine, only eight diseases have been increasing in prevalence and shortening human lives because of premature deaths according to the retrospective official review on the state of US health, 1990-2010. These diseases are kidney cancer, chronic kidney diseases, liver cancer, diabetes, drug addiction, poisoning cases, consequences of falls, and Alzheimer's disease (AD) as one of the leading pathologies. There are familial AD of hereditary nature (~4% of cases) and sporadic AD of unclear etiology (remaining ~96% of cases; i.e., non-familial AD). Therefore, sporadic AD is no longer a purely medical problem, but rather a social challenge when someone asks oneself: "What can I do in my own adulthood to reduce the risk of sporadic AD at my old age to save the years of my lifespan from the destruction caused by it?" Here, we combine two computational approaches for regulatory SNPs: Web service SNP_TATA_Comparator for sequence analysis and a PubMed-based keyword search for articles on the biochemical markers of diseases. Our purpose was to try to find answers to the question: "What can be done in adulthood to reduce the risk of sporadic AD in old age to prevent the lifespan reduction caused by it?" As a result, we found 89 candidate SNP markers of familial and sporadic AD (e.g., rs562962093 is associated with sporadic AD in the elderly as a complication of stroke in adulthood, where natural marine diets can reduce risks of both diseases in case of the minor allele of this SNP). In addition, rs768454929, and rs761695685 correlate with sporadic AD as a comorbidity of short stature, where maximizing stature in childhood and adolescence as an integral indicator of health can minimize (or even eliminate) the risk of sporadic AD in the elderly. After validation by clinical protocols, these candidate SNP markers may become interesting to the general population [may help to choose a lifestyle (in childhood, adolescence, and adulthood) that can reduce the risks of sporadic AD, its comorbidities, and complications in the elderly].

KW - Alzheimer's disease

KW - Expression change

KW - Gene

KW - Promoter

KW - Single nucleotide polymorphism

KW - SNP marker

KW - TATA-binding protein

KW - TBP-binding site

KW - TRANSCRIPTION FACTOR-BINDING

KW - MYOCARDIAL-INFARCTION

KW - gene

KW - single nucleotide polymorphism

KW - AMYOTROPHIC-LATERAL-SCLEROSIS

KW - POLYMERASE-II TRANSCRIPTION

KW - SENILE PLAQUES

KW - DIABETES-MELLITUS

KW - HUMAN HEREDITARY-DISEASES

KW - expression change

KW - AMYLOID-BETA

KW - MOUSE MODEL

KW - promoter

KW - PARKINSONS-DISEASE

UR - http://www.scopus.com/inward/record.url?scp=85027168071&partnerID=8YFLogxK

U2 - 10.3389/fnagi.2017.00231

DO - 10.3389/fnagi.2017.00231

M3 - Article

C2 - 28775688

AN - SCOPUS:85027168071

VL - 9

SP - 231

JO - Frontiers in Aging Neuroscience

JF - Frontiers in Aging Neuroscience

SN - 1663-4365

IS - JUL

M1 - 231

ER -

ID: 9965653